SAPHO syndrome
Synovitis, acne, pustulosis, hyperostosis · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A rare chronic disorder linking osteoarticular inflammation (synovitis, hyperostosis, osteitis) with skin lesions such as palmoplantar pustulosis and severe acne. The anterior chest wall is the most characteristic site of bone involvement.
Red flags
- Rapidly progressive bone pain or mass (exclude malignancy)
- Fever with bone lesion (exclude infection)
- Neurological compromise from vertebral involvement
- Spinal instability from hyperostosis
- Non-resolving lesion despite therapy
Assessment
Differential diagnosis
- Chronic osteomyelitis (infective)
- Bone metastasis / primary bone tumour
- Psoriatic arthritis
- Ankylosing spondylitis
- Paget disease of bone
- Chronic recurrent multifocal osteomyelitis (paediatric equivalent)
Investigations
- CRP/ESR (often mildly raised)
- Radiographs / CT of anterior chest wall and affected bones (hyperostosis, osteitis)
- Whole-body MRI or bone scintigraphy ('bull's head' sign over sternoclavicular joints)
- Bone biopsy if malignancy or infection needs exclusion
- Skin assessment for palmoplantar pustulosis / acne
- HLA-B27 (variable)
Management
- Correlate osteoarticular inflammation (especially anterior chest wall) with characteristic skin lesions
- Image with bone scintigraphy or whole-body MRI to map multifocal involvement
- Exclude infection and malignancy with biopsy when imaging is atypical
- Start NSAIDs as first-line for bone pain and inflammation
- Add bisphosphonates for refractory osteitis/bone pain
- Use conventional DMARDs (methotrexate, sulfasalazine) for persistent synovitis
- Consider anti-TNF therapy for refractory disease
- Treat the associated skin disease in parallel
Drugs & doses
Naproxen — 500 mg PO BD (with gastroprotection) as first-line
Pamidronate — 60 mg IV (single or repeated per protocol) for refractory osteitis
Methotrexate — 15-25 mg PO/SC once weekly with folic acid
Infliximab — 5 mg/kg IV at 0, 2, 6 weeks then 8-weekly for refractory disease
Doxycycline — 100 mg PO OD if acne component contributes
Disposition
Outpatient rheumatology (with dermatology) management; admission only to exclude infection/malignancy or for severe pain.
Complications & pitfalls
- Chronic pain and functional limitation
- Vertebral involvement / spinal complications
- Sternoclavicular hyperostosis with venous compression
- Misdiagnosis as infection or tumour
- Skin disease morbidity
Exam pearls
- Anterior chest wall involvement with palmoplantar pustulosis is the key diagnostic combination
- The 'bull's head' appearance on bone scan reflects sternoclavicular uptake
- Cutibacterium acnes is implicated but SAPHO is not a true infection
- Bisphosphonates are useful for steroid-sparing control of osteitis
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.